Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlushCare vs Queen RX

PlushCare
Graded #63

Higher grade

vs+8.200000000000003
Queen RX
Graded #192

Lower grade

The verdict

PlushCare takes it — 74.5/100 to 66.3/100.

PlushCare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +3
74
77
Dose & formulationPlushCare +20
77
57
Clinical oversightPlushCare +13
82
69
Labs & monitoringPlushCare +24
77
53
FulfillmentPlushCare +3
78
75
Contract termsQueen RX +20
41
61
PlushCare · left barQueen RX · right bar

The numbers

MetricPlushCareQueen RX
WeighScore74.5/10066.3/100
GradeCC
Scorecard rank#63#192
Semaglutide$149/mo (starting dose, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$399/mo (starting dose, compounded)Not disclosed
CoverageAll 50 states45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
PlushCare

Graded #63 · C

Strengths

  • Available in all 50 states
  • Appointments with US board-certified physicians, not nurse practitioners only
  • Virtual primary care — the same doctor can manage GLP-1s alongside other health needs
  • Owned by Transcarent, a venture-backed health platform with a named corporate parent

Where it loses points

  • Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
  • GLP-1 prescribing is up to the clinician at the visit — not guaranteed at signup
  • BBB complaints center on the membership cancellation process
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard